Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The price of BriaCell Therapeutics Corp (NASDAQ: BCTX) closed at $0.81 in the last session, up 0.25% from day before closing price of $0.8. In other words, the price has increased by $0.25 from its previous closing price. On the day, 0.64 million shares were traded. BCTX stock price reached its highest trading level at $0.805 during the session, while it also had its lowest trading level at $0.7802.
Ratios:
We take a closer look at BCTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 14, 2022, initiated with a Buy rating and assigned the stock a target price of $25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCTX now has a Market Capitalization of 5454752 and an Enterprise Value of -7493109.
Stock Price History:
The Beta on a monthly basis for BCTX is 1.10, which has changed by 0.05194807 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, BCTX has reached a high of $29.40, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is -71.23%, while the 200-Day Moving Average is calculated to be -87.57%.
Shares Statistics:
According to the various share statistics, BCTX traded on average about 1.91M shares per day over the past 3-months and 4158230 shares per day over the past 10 days. A total of 17.55M shares are outstanding, with a floating share count of 16.42M. Insiders hold about 6.47% of the company’s shares, while institutions hold 1.42% stake in the company. Shares short for BCTX as of 1751241600 were 329936 with a Short Ratio of 0.11, compared to 1748563200 on 517532. Therefore, it implies a Short% of Shares Outstanding of 329936 and a Short% of Float of 4.97.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
